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Pancreatic secretory trypsin inhibitor (PSTI) was purified from canine pancreatic juice by HPLC. Canine 
PST1 inhibited bovine trypsin activity stoichiometrically and strongly with a dissociation constant of below 
10mg M. The amino acid sequence of canine PST1 was determined by conventional methods. It had one 
more amino acid residue at the amino-terminus than other mammalian PSTIs, i.e. human, porcine, bovine 
and ovine. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
PST1 is produced in acinar cells of the pancreas 
and secreted into the pancreatic juice. The RIA 
system of human PST1 was established by Ed- 
deland and Ohlsson [l] and Kitahara et al. [2,3]. 
Ogawa [4] reported that measurement of the serum 
concentration of PST1 could aid estimation of the 
state of acute pancreatitis. However, the human 
PST1 RIA system cannot be used to assay other 
mammalian PSTIs [3]. Establishment of the RIA 
system of a mammalian PST1 should enable fur- 
ther study of the state of acute pancreatitis with an 
experimental acute pancreatitis model. As a step in 
this direction, we purified canine PST1 from 
canine pancreatic juice and determined its amino 
acid sequence. 
2.1. Materials 
Canine pancreatic juice was collected by 
catheterization of the pancreatic duct after related 
surgical procedures. Bovine trypsin (treated with 
N-tosyl-L-phenylalanyl chloromethyl ketone) and 
cu-chymotrypsin were purchased from Wor- 
thington. SPase was from Miles Laboratories. 
2.2. Amino acid analyses and sequence deter- 
mination 
Samples were hydrolyzed according to Simpson 
et al. [5], at 110°C for 24 h, and amino acid 
analyses were performed with a Hitachi amino acid 
analyzer (model 835). Sequence determination was 
carried out as described by Kikuchi et al. [6]. 
Abbreviations: PSTI, pancreatic secretory trypsin in- 
hibitor; RIA, radioimmunoassay; SPase, Staphylococ- 
cus aureus V8 protease 
2.3. Determination of trypsin inhibitory activity 
Trypsin inhibitory activity was determined from 
the residual trypsin activity after mixing trypsin 
with inhibitor, using N-benzoyl-L-arginine p- 
nitroanilide as the substrate [6]. 
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3. RESULTS AND DISCUSSION 
3.1. Purification of canine PSTI 
Canine pancreatic juice (200 ml) was adjusted to 
pH 4.5 and centrifuged at 10000 x g for 20 min. 
The supernatant was subjected to gel filtration on 
a Sephadex G-50 column (10.5 x 101 cm) 
previously equilibrated with 0.1 M ammonium 
acetate buffer (pH 4.5). Fractions displaying tryp- 
sin inhibitory activity were pooled, adjusted to pH 
7.3 and equal volumes of distilled water were add- 
ed. The samples were then applied to an SP- 
Sephadex C-25 column (1.5 x 41 cm) equilibrated 
with 0.05 M ammonium acetate buffer (pH 7.3), 
and proteins were eluted with a linear gradient of 
O-O.5 M NaCl. The PST1 fractions were pooled, 
dialyzed against distilled water and lyophilized. 
They were dissolved in a minimum volume of 
distilled water and subjected to reversed-phase 
HPLC with a column of Nucleosil Cl8 (Nagel, 
5 pm, 4.6 x 150 mm) and 0.01 M ammonium 
acetate buffer (pH 4.5) as the solvent. Canine 
PST1 eluted with a linear gradient of 20-30070 
acetonitrile (fig.1) showed a single band on 
polyacrylamide gel electrophoresis at pH 4.3 in 
7.5% gel [7]. The purified canine PST1 obtained 
amounted to 560,ug from 200 ml pancreatic juice 
with a total activity yield of 30%. We were able to 
purify only one form of canine PST1 with 
reproducible results, although 3 forms were ob- 
tained by Eddeland and Ohlsson [8]. Human PST1 
also has multiple chromatographic forms [9- 111, 
and porcine PST1 has inhibitors lacking 4 or 5 
amino-terminal amino acid residues from the 
native PST1 [12,13]. Kikuchi et al. [6] reported 
that different samples of human pancreatic juice 
showed great fluctuation in the 4 forms of PSTI. 
Thus, the canine pancreatic juice that we used in 
this study may have only had one PST1 form. 
3.2. Trypsin inhibitory activity of canine PSTI 
Canine PST1 inhibited bovine trypsin activity 
stoichiometrically (fig.%) and the approximate 
dissociation constant at pH 8 was below 10m9 M, 
when the method of Green and Work [14] was 
used. 
3.3. Amino acid composition and partial amino- 
terminal sequence of canine PSTI 
The amino acid composition of canine PST1 
listed in table 1 shows 57 amino acid residues in 
total, which indicated canine PST1 had one amino 
acid residue more than other mammalian PSTIs, 
i.e. human, porcine, bovine and ovine [15]. The 
amino acid sequence of the 7 amino-terminal 
residues of native canine PST1 was determined by 
the manual Edman method to be Asn’-Asn-Met- 
Leu-Gln-Arg-Gin’. 
3.4. Amino acid sequence of canine PSTI 
Canine PST1 was reduced and S- 
carboxymethylated (RCm-) by the method of 
Crestfield et al. [ 161. RCm-canine PST1 
ELUSION TIME (MINI 
Fig. 1. Purification of canine PST1 by HPLC. Canine 
PST1 from SP-Sephadex C-25 was applied to a Nucleosil 
Cl8 column @pm, 4.6 x 150 mm) equilibrated with 
0.01 M ammonium acetate buffer (pH 4.5), and eluted 
with a linear gradient of 20-30% acetonitrile. (-) 
Absorbance at 280 nm, (- --) acetonitrile con- 
centration. 
[CANINE PsTj /[BOVINE TFHPSIfl 
Fig.2. Trypsin inhibitory activity of canine PSTI. 
Trypsin concentration in the reaction mixture was 
1.25 x lo-’ M. 
270 
Volume 191, number 2 FEBS LETTERS October 1985 
Table 1 
Amino acid composition of canine PST1 
Amino acid Canine PST1 
Asp 9.9 (10) 
Thr 1.9 ( 2) 
Ser 2.7 ( 3) 
ClU 6.0 ( 6) 
Pro 1.9 ( 2) 
ClY 3.9 ( 4) 
Ala 2.0 ( 2) 
1/2cys 5.3 ( 2) 
Val 2.0 ( 2) 
Met 0.9 ( 1) 
Ile 3.7 ( 4) 
Leu 5.9 ( 6) 
Tyr 2.0 ( 2) 
Phe 0.0 ( 0) 
LYS 4.8 ( 5) 
His 0.0 ( 0) 
Trp 0.0 ( 0) 
Au 2.0 ( 2) 
Total 57 
The numbers of residues are from the established 
sequence 
(47.5 nmol) was digested with SPase and separated 
by HPLC as described by Kikuchi et al. [6]. Four 
SPase peptides (S-l to S-4) were obtained and the 
amino acid sequences of S-2, S-3 and S-4 were 
determined as shown in fig.3. The whole amino 
acid sequence of S-l was determined after*further 
digestion by trypsin, which yielded 4 peptides 
(Sl-Tl to Sl-T4). As the amino acid sequence of 
S-l corresponded to that of native canine PSTI, 
S-l was the amino-terminal peptide. From the 
substrate specificity of SPase, S-4, which did not 
have glutamic acid at the carboxyl-terminus, was 
probably the ~~boxyl-terminal peptide. RCm- 
canine PSTI (15 nmol) was digested with trypsin 
(0.06 nmol) at 37°C for 4 h, the digests were 
separated by HPLC (as in the case of SPase diges- 
tion) and 7 peptides (T-l to T-7) were obtained. 
T-l, T-2 and T-3 corresponded to Sl-Tl, Sl-T2 
and Sl-T3, respectively, according to their amino 
acid compositions. T-4 (8 nmol) was digested with 
a-chymotrypsin (0.02 nmol) at 25’C for 30 min. 
Two peptides, T4-Cl and T4-C2, were separated 
using HPLC (as in the case of SPase digestion). 
T4-C2 covered the amino acid sequence of the S-l 
carboxyl-terminal region, the whole sequence of 
S-2 and the S-3 Gino-terming region. Thus the 
sequence of the SPase peptides of Rem-canine 
PST1 was determined to be S-l, S-2, S-3 and S-4 in 
that order. These results are summarized in fig.3. 
3.5. Comparison of amino acid sequences of 
canine, human, porcine, bovine and ovine 
PS Tis 
The amino acid sequence of canine PST1 was 
compared with those of human, porcine, bovine 
and ovine [15] (fig.4). Canine PST1 had one more 
amino acid residue at the amino-terminus than the 
other mammalian PSTIs. These PSTIs had 54% 
homology, but it was lower near the amino- 
terminus than in the other positions. Anti-human 
PST1 antibody possesses no reactivity to canine 
PST1 (not shown), and the recognition site of anti- 
PST1 antibody to PST1 may exist around the 
amino-terminus. 
S-1 
__a~__bu__--.----~----- 
- Sl-T3 --+ 'Y ST-T4 
--- 
- T-3 --+ 
_...ZX_...d- 
TI-Cl 
40 
--4 
I--. T-6 "I ~-‘-'--?=-I 
Fig.3. Amino acid sequence of canine PSTI. (---) 
Manual Edman degradation, (-) carboxypeptidase P
digestion, (-) amino acid identified as a free amino acid 
when the residual peptide after Edman degradation was 
analyzed with an amino acid analyzer. 
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Fig.4. Comparison of amino acid sequences of canine, 
human, porcine, bovine and ovine PSTIs. In human 
PSTI, Asp” and Asnz9 differed from those reported by 
Greene et al. [IS]; these data were reported by Kikuchi 
et al. 161. Identical amino acids are framed. 
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